Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
American Journal of Hematology|May 1, 1990
Cyclosporin for treatment of life-threatening alloimmunizationH Tilly, M Azagury, D Bastit, et al.American Journal of Clinical Oncology|April 1, 1993
VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remissionM Azagury, B Chevallier, D Atlan, et al.Blood|December 15, 1995
Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patientsE A Macintyre, C Belanger, C Debert, et al.Leukemia|January 22, 1998
Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphomaL Mauvieux, D Canioni, O Hermine, et al.Bone Marrow Transplantation|March 7, 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patientsF Lefrère, S Zohar, D Ghez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative GroupJ M Tourani, C Pfister, J F Berdah, et al.Pageof 1